Related references
Note: Only part of the references are listed.Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats
Ching-Heng Ting et al.
NUTRITION (2015)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: G PROTEIN-COUPLED RECEPTORS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Cannabinoid Receptor 2 Expression in Human Proximal Tubule Cells is Regulated by Albumin Independent of ERK1/2 Signaling
Kayte A. Jenkin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
Maryam Afkarian et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Time-course morphological and functional disorders of the kidney induced by long-term high-fat diet intake in female rats
Carolina Staut Pinhal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Adipokines as a link between obesity and chronic kidney disease
Jessica F. Briffa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Blockade of Cannabinoid Receptor 1 Improves Insulin Resistance, Lipid Metabolism, and Diabetic Nephropathy in db/db Mice
D. H. Nam et al.
ENDOCRINOLOGY (2012)
Endocannabinoids and the renal proximal tubule: An emerging role in diabetic nephropathy
Kayte A. Jenkin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Overexpression of Cannabinoid CB2 Receptor in the Brain Induces Hyperglycaemia and a Lean Phenotype in Adult Mice
S. Y. Romero-Zerbo et al.
JOURNAL OF NEUROENDOCRINOLOGY (2012)
Diet-induced Obesity Up-regulates the Abundance of GPR43 and GPR120 in a Tissue Specific Manner
Lauren M. Cornall et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
Federica Barutta et al.
DIABETES (2011)
AMPK Mediates the Initiation of Kidney Disease Induced by a High-Fat Diet
Anne-Emilie Decleves et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Cellular and molecular mechanisms of renal fibrosis
Youhua Liu
NATURE REVIEWS NEPHROLOGY (2011)
Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
Xuan Xia et al.
PLOS ONE (2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P. Pacher et al.
PROGRESS IN LIPID RESEARCH (2011)
Obesity Related Kidney Disease
Anna V. Mathew et al.
CURRENT DIABETES REVIEWS (2011)
Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis
Amelie Servettaz et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain
V. Curto-Reyes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Role for Cannabinoid Receptors in Human Proximal Tubular Hypertrophy
Kayte A. Jenkin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
J. Agudo et al.
DIABETOLOGIA (2010)
Endocannabinoid biosynthesis and inactivation, from simple to complex
Giulio G. Muccioli
DRUG DISCOVERY TODAY (2010)
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy
Partha Mukhopadhyay et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Dietary Sodium in Chronic Kidney Disease: A Comprehensive Approach
Julie A. Wright et al.
SEMINARS IN DIALYSIS (2010)
The biochemical pharmacology of renin inhibitors: Implications for translational medicine in hypertension, diabetic nephropathy and heart failure: Expectations and reality
Zaid Abassi et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
Guy A. Cabral et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
Vanessa Deveaux et al.
PLOS ONE (2009)
Biology of endocannabinoid synthesis system
Jun Wang et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2009)
Behavioral Effects of CB2 Cannabinoid Receptor Activation and Its Influence on Food and Alcohol Consumption
E. S. Onaivi et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients Effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes
Julio Rosenstock et al.
DIABETES CARE (2008)
Different roles for TGF-β and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy
Fuad N. Ziyadeh
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
The endocannabinoid system in obesity and type 2 diabetes
V. Di Marzo
DIABETOLOGIA (2008)
Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor
Aymen I. Idris et al.
ENDOCRINOLOGY (2008)
Transforming growth factor-beta/connective tissue growth factor axis in the kidney
Weier Qi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Association between obesity and kidney disease: A systematic review and meta-analysis
Y. Wang et al.
KIDNEY INTERNATIONAL (2008)
Dysregulation of peripheral endocannabinoid levels in hyperglycernia and obesity: Effect of high fat diets
Isabel Matias et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance
Anura P. Jayasooriya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats
Javier Munoz-Luque et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats
P. Janiak et al.
KIDNEY INTERNATIONAL (2007)
Obesity and kidney disease
Mauro Cignarelli et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2007)
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
Jennifer L. Shoemaker et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Transforming growth factor-β1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells
Weier Qi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Effects of tight blood pressure control on glomerular hypertrophy in a model of genetic hypertension and experimental diabetes mellitus
Roberto Bleuel Amazonas et al.
LIFE SCIENCES (2006)
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes
M Gary-Bobo et al.
MOLECULAR PHARMACOLOGY (2006)
Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain
CJ LaBuda et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Obesity and prevalent and incident CKD: The hypertension detection and follow-up program
H Kramer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Blood pressure regulation by endocannabinoids and their receptors
P Pacher et al.
NEUROPHARMACOLOGY (2005)
Obesity and the built environment
KM Booth et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2005)
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients:: 1-year experience from the RIO-Europe study
LF Van Gaal et al.
LANCET (2005)
Molecular changes in proximal tubule function in diabetes mellitus
DH Hryciw et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2004)
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors
S Mukherjee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
The cannabinoid system and immune modulation
TW Klein et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain:: Pain inhibition by receptors not present in the CNS
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Protein uptake disturbs collagen homeostasis in proximal tubule-derived cells
V Wohlfarth et al.
KIDNEY INTERNATIONAL (2003)
Obesity and target organ damage: the kidney
PE de Jong et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression
J Kanellis et al.
KIDNEY INTERNATIONAL (2002)
Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-β
B Gardner et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Leptin and renal disease
G Wolf et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Chronic nephropathy in ad libitum overfed Sprague-Dawley rats and its early attenuation by increasing degrees of dietary (caloric) restriction to control growth
KP Keenan et al.
TOXICOLOGIC PATHOLOGY (2000)
Role of vascular endothelial growth factor in diabetic nephropathy
DR Cha et al.
KIDNEY INTERNATIONAL (2000)
Development of hypertension in a rat model of diet-induced obesity
AD Dobrian et al.
HYPERTENSION (2000)
Share Paper
